1 month Company News for Aug 21, 2024 Zacks Companies In The News Are: LLY, BA, AS, MDT. Eli Lilly (LLY)
11 hours BioAge Labs, An Obesity Newcomer And Eli Lilly Partner, Rises On Upsized IPOInvestor's Business Daily
6 days Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher TodayThe Motley Fool
1 week Eli Lilly and Company (LLY): Hedge Funds Are Bullish On This Counter Cyclical and Defensive Stock to Invest InInsider Monkey
1 week This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly’s Weight-Loss TreatmentsThe Motley Fool
1 week This Small-Cap Stock Has a Promising GLP-1 Drug That Could Rival Novo Nordisk’s and Eli Lilly’s Weight Loss TreatmentsThe Motley Fool
2 weeks Drugmakers bet billions that targeted radiation could become the next cancer breakthroughCNBC
2 weeks World’s Biggest Hedge Fund Sells Apple, Eli Lilly Stock, and Buys Microsoft, ModernaYahoo Finance
2 weeks Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right NowYahoo Finance
2 weeks Roche stock is falling after report its Wegovy challenger is causing patients to vomitFortune
2 weeks Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes, Alzheimer’s drugsCNBC
2 weeks Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I’m Not Talking About Zepbound)The Motley Fool
3 weeks Beyond Mounjaro and Zepbound: 6 Other Drugs That Could Be Blockbusters for Eli LillyThe Motley Fool
3 weeks Jim Cramer Says Eli Lilly and Company (LLY) Has the Biggest Pharmaceutical PotentialInsider Monkey
3 weeks Does Eli Lilly and Company (LLY)’s Financial Performance Make It A Safe Stock To Invest In Now?Insider Monkey
3 weeks This Big Move by Eli Lilly May Solve the Weight Loss Drug Market’s Biggest ProblemYahoo Finance
3 weeks Eli Lilly and Company (LLY) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)Seeking Alpha
3 weeks Eli Lilly Just Made Zepbound Even More Appealing. Here’s What Smart Investors Need to Know.The Motley Fool
3 weeks How Lilly, Novo Could Beat Tesla To The Trillion-Dollar Club; Plus, Nvidia’s Battle With Microsoft, AppleInvestor's Business Daily
3 weeks Eli Lilly Trades Near All-Time High: Check Out The IBD 50, Big Cap 20, Other Top Stock ListsInvestor's Business Daily
3 weeks Novo Nordisk’s Ozempic Shortage Is Worsening. It’s Good News For Eli Lilly Stock.Yahoo Finance
3 weeks Novo Nordisk Says Ozempic Shortage Is Worsening. Why It’s Good News For Eli Lilly.Yahoo Finance
4 weeks Tech market values fall on AI costs and recession fears; Eli Lilly, Berkshire gainYahoo Finance
4 weeks These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo Nordisk Right NowThe Motley Fool
4 weeks Think Eli Lilly Stock Has Peaked? These 10 Words From the CEO May Change Your MindThe Motley Fool
4 weeks Is Eli Lilly Stock a No-Brainer Buy After the Company’s Brilliant Zepbound Move?The Motley Fool
1 month Eli Lilly’s Stock Keeps Looking Better and Better. Here’s the Latest Reason Why.The Motley Fool
1 month Eli Lilly’s Zepbound single-dose vials will expand access to more patients: Mizuho’s Jared HolzYouTube
1 month Eli Lilly says weight-loss drug Zepbound now available in 2.5- and 5-milligram vials at 50% discountMarketWatch
1 month Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supplyYouTube
1 month Obesity drugs’ next wave: These companies could snag 20% of GLP-1 market, analysts sayMarketWatch
1 month If You Like Eli Lilly, Then You’ll Love This Little-Known Specialty Manufacturing StockThe Motley Fool
1 month These Were the Top-Selling GLP-1 Drugs Last Quarter From Eli Lilly and Novo NordiskThe Motley Fool
1 month Eli Lilly Hits All-Time High, Gets Watchlist Trifecta: These Names Just Added To IBD 50, Other Top Stock ScreensInvestor's Business Daily
1 month This Undervalued Stock Could Join the Race With Eli Lilly to the $1 Trillion ClubYahoo Finance
1 month Eli Lilly Stock Could Soar to $1,150, According to a Wall Street Analyst. Is It a Buy at Around $945?The Motley Fool
1 month Zacks Investment Ideas feature highlights: Viking Therapeutics, McDonalds, Starbucks, Novo Nordisk and Eli LillyZacks
1 month Eli Lilly’s Zepbound may be best-in-breed for weight loss drugs, says Dr. Kavita PatelYouTube